Behind the Buzz of GLP-1s: Side Effects, Long-Term Risks, and Weight Loss at All Costs with Ragen Chastain (Best of)
This is a free preview of a paid episode. To hear more, visit abbieattwoodwellness.substack.com Ragen Chastain is back to continue our conversation about weight, health, and diet culture — this time answering listener questions about the GLP-1s you’ve been hearing so much about: Wegovy, Ozempic, and other weight-loss drugs. Following up on last week’s episode, Ragen helps us separate hype from reality. We dive into how these drugs actually work — and don’t — their risks and side effects, and the broader context around the pharmaceutical industry and public discourse on weight. In this episode, we cover: What GLP-1s actually are and how they function in the body The side effects and potential health risks of these drugs How effective they really are for long-term weight management What happens when weight loss plateaus while taking them The impact of pharma companies, marketing, and the weight-loss industry The shortages affecting diabetics who rely on GLP-1s for medical reasons Tune in to get a clear, evidence-based perspective on the weight-loss drug craze, and to continue unpacking the bigger conversation about weight, health, and stigma. Support the show: Enjoying this podcast? Please support the show on Substack for bonus episodes, community engagement, and access to "Ask Abbie" at abbieattwoodwellness.substack.com/subscribe Apply for Abbie’s Group Membership: Already been at this anti-diet culture thing for a while, but want community and continued learning? Apply for Abbie's monthly membership: https://www.abbieattwoodwellness.com/circle-monthly-group Social media: Find the show on Instagram: @fullplate.podcast Find Abbie on Instagram: @abbieattwoodwellness Podcast Cover Photography by Anya McInroy Podcast Editing by Brian Walters This podcast is ad-free and support comes from your support on Substack. Subscribe HERE.
From "The Full Plate Podcast with Abbie Attwood, MS"
Comments
Add comment Feedback